Lymphocyte Cytosolic Protein 1 (LCP1) Peptide
Quick Overview for Lymphocyte Cytosolic Protein 1 (LCP1) Peptide (ABIN938315)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- FIKIFHGLKS TDVAKTFRKA INKKEGICAI GGTSEQSSVG TQHSYSEEEK
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LCP1 antibody,
Alternative Names: LCP1 control peptide, LCP1 antibody Blocking Peptide, Anti-LCP1 Blocking Peptide, Lymphocyte Cytosolic Protein 1 Blocking Peptide, L-Plastin Blocking Peptide, CP64 Blocking Peptide, DKFZp781A23186 Blocking Peptide, FLJ25423 Blocking Peptide, FLJ26114 Blocking Peptide, FLJ39956 Blocking Peptide, L-PLASTIN Blocking Peptide, LC64P Blocking Peptide, PLS2 Blocking Peptide, LCP1, LCP-1, LCP 1, LCP-1 Blocking Peptide, LCP 1 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- LCP1 (Lymphocyte Cytosolic Protein 1 (LCP1))
-
Background
- Plastins are a family of actin-binding proteins that are conserved throughout eukaryote evolution and expressed in most tissues of higher eukaryotes. In humans, two ubiquitous plastin isoforms (L and T) have been identified. The L isoform is expressed only in hemopoietic cell lineages. However, L-plastin has been found in many types of malignant human cells of non-hemopoietic origin suggesting that its expression is induced accompanying tumorigenesis in solid tissues.
-
Molecular Weight
- 70 kDa
Target
-